Table of Contents
ISRN Addiction
Volume 2013, Article ID 723131, 13 pages
http://dx.doi.org/10.1155/2013/723131
Research Article

The Choice of Screening Instrument Matters: The Case of Problematic Cannabis Use Screening in Spanish Population of Adolescents

1Prevalence and Consequences and Data Management Unit, European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Cais do Sodré, 1249-289 Lisbon, Portugal
2IMIM-Hospital del Mar, CIBERESP, Dr. Aiguader 88, 08003 Barcelona, Spain
3Escuela Nacional de Sanidad, Instituto de Salud Carlos III, CIBERESP, Avenida Monforte de Lemos 5, 28029 Madrid, Spain
4Unidad de Conductas Adictivas, Departamento de Salud Valencia, Hospital Arnau de Villanova, Plaza Clot de Joan s/n, Paterna, 46980 Valencia, Spain
5Delegación del Gobierno para el Plan Nacional sobre Drogas (DGPNSD), Ministerio de Sanidad, Servicios Sociales e Igualdad, Plaza de España 17, 28071 Madrid, Spain
6Agència de Salut Pública de Catalunya, Departament de Salut de la Generalitat de Catalunya, Roc Boronat 81-95, 08005 Barcelona, Spain

Received 22 August 2012; Accepted 24 September 2012

Academic Editors: K. M. Beaver, K. Dalen, M. Farris, and P. Mannelli

Copyright © 2013 Danica Thanki et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. World Drug Report, United Nations Office on Drugs and Crime (UNODC), Vienna, Austria, 2012.
  2. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Table GPS-9 Part iii. EMCDDA Statistical Bulletin Online, 2012, http://www.emcdda.europa.eu/stats12#display:/stats12/gpstab9c.
  3. C. Currie, C. Zanotti, and A. Morgan, Eds., “Social determinants of health and well-being among young people. Health Behaviour in School-aged Children (HBSC) study: International report from the 2009/2010 survey,” WHO Regional Office for Europe, Copenhagen, Denmark, 2012.
  4. European Monitoring Centre for Drugs and Drug Addiction (EMCDDA), Table EYE-9 Part I. EMCDDA Statistical Bulletin Online, 2012, http://www.emcdda.europa.eu/stats12#display:/stats12/eyetab9a.
  5. W. Hall and L. Degenhardt, “Adverse health effects of non-medical cannabis use,” The Lancet, vol. 374, no. 9698, pp. 1383–1391, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Lynskey and W. Hall, “The effects of adolescent cannabis use on educational attainment: a review,” Addiction, vol. 95, no. 11, pp. 1621–1630, 2000. View at Publisher · View at Google Scholar · View at Scopus
  7. D. M. Fergusson and J. M. Boden, “Cannabis use and later life outcomes,” Addiction, vol. 103, no. 6, pp. 969–976, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. P. Casadio, C. Fernandes, R. M. Murray, and M. Di Forti, “Cannabis use in young people: the risk for schizophrenia,” Neuroscience and Biobehavioral Reviews, vol. 35, no. 8, pp. 1779–1787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. T. H. Moore, S. Zammit, A. Lingford-Hughes et al., “Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review,” Lancet, vol. 370, no. 9584, pp. 319–328, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. Annual Report, The State of the Drugs Problem in Europe. Lisbon, Portugal. European Monitoring Centre for Drugs and Drug Addiction, 2012.
  11. S. Steiner, S. E. Baumeister, and L. Kraus, “Severity of dependence scale: establishing a cut-off point for cannabis dependence in the German adult population,” Sucht, vol. 54, no. 1, pp. S57–S63, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. B. Annaheim, J. Rehm, and G. Gmel, “How to screen for problematic cannabis use in population surveys? An Evaluation of the Cannabis Use Disorders Identification Test (CUDIT) in a Swiss Sample of Adolescents and young Adults,” European Addiction Research, vol. 14, no. 4, pp. 190–197, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Okulicz-Kozaryn, “Ocena psychometrycznych wlasciwosci testu “Problemowe uzywanie marihuany” (PUM) dla dorastajacych,” Postepy Psychiatrii i Neurologii, vol. 2, pp. 105–111, 2007. View at Google Scholar
  14. S. Legleye, L. Karila, F. Beck, and M. Reynaud, “Validation of the CAST, a general population cannabis abuse screening test,” Journal of Substance Use, vol. 12, no. 4, pp. 233–242, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Legleye, D. Piontek, and L. Kraus, “Psychometric properties of the Cannabis Abuse Screening Test (CAST) in a French sample of adolescents,” Drug and Alcohol Dependence, vol. 113, no. 2-3, pp. 229–235, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Hibell, U. Guttormsson, S. Ahlström et al., “The 2007 ESPAD Report -Substance use among Students in 35 European Countries. Stockholm, Sweden. The Swedish Council for Information on Alcohol and Other Drugs (CAN),” 2009.
  17. B. Hibell, U. Guttormsson, S. Ahlström et al., The 2011 ESPAD Report. Substance use among Students in 36 European Countries. Stockholm, Sweden. The Swedish Council for Information on Alcohol and Other Drugs (CAN), 2012.
  18. A. Sanchez and D. Klempova, “Screening for problem or dependent cannabis use,” Drugnet Europe, vol. 58, article 2.
  19. R. C. Kessler, P. R. Barker, L. J. Colpe et al., “Screening for serious mental illness in the general population,” Archives of General Psychiatry, vol. 60, no. 2, pp. 184–189, 2003. View at Publisher · View at Google Scholar · View at Scopus
  20. P. C. Smith, S. M. Schmidt, D. Allensworth-Davies, and R. Saitz, “Primary care validation of a single-question alcohol screening test,” Journal of General Internal Medicine, vol. 24, no. 7, pp. 783–788, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Piontek, L. Kraus, and D. Klempova, “Short scales to assess cannabis-related problems: a review of psychometric properties,” Substance Abuse, vol. 3, article 25, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. Substance Abuse and Mental Health Services Administration (SAMHSA), Office of Applied Studies, “Appendix C: Measurement of Dependence, Abuse, Treatment, and Treatment Need. In: Substance Dependence, Abuse and Treatment: Findings from the 2000 National Household Survey on Drug Abuse,” 2010, http://www.oas.samhsa.gov/Dependence/appendixc.htm.
  23. Diagnostic and Statistical Manual of Mental Disorders, American Psychiatric Association, Washington, DC, USA, 1994.
  24. M. Gossop, S. Darke, P. Griffiths et al., “The severity of dependence scale (SDS): psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users,” Addiction, vol. 90, no. 5, pp. 607–614, 1995. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Swift, J. Copeland, and W. Hall, “Choosing a diagnostic cut-off for cannabis dependence,” Addiction, vol. 93, no. 11, pp. 1681–1692, 1998. View at Google Scholar · View at Scopus
  26. C. P. Ferri, J. Marsden, M. De Araujo, R. R. Laranjeira, and M. Gossop, “Validity and reliability of the Severity of Dependence Scale (SDS) in a Brazilian sample of drug users,” Drug and Alcohol Review, vol. 19, no. 4, pp. 451–455, 2000. View at Publisher · View at Google Scholar · View at Scopus
  27. G. Martin, J. Copeland, P. Gates, and S. Gilmour, “The Severity of Dependence Scale (SDS) in an adolescent population of cannabis users: reliability, validity and diagnostic cut-off,” Drug and Alcohol Dependence, vol. 83, no. 1, pp. 90–93, 2006. View at Publisher · View at Google Scholar · View at Scopus
  28. W. Swift, W. Hall, and J. Copeland, “One year follow-up of cannabis dependence among long-term users in Sydney, Australia,” Drug and Alcohol Dependence, vol. 59, no. 3, pp. 309–318, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. H. U. Wittchen, S. Behrendt, M. Höfler et al., “A typology of cannabis-related problems among individuals with repeated illegal drug use in the first three decades of life: evidence for heterogeneity and different treatment needs,” Drug and Alcohol Dependence, vol. 102, no. 1–3, pp. 151–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  30. W. M. Compton, T. D. Saha, K. P. Conway, and B. F. Grant, “The role of cannabis use within a dimensional approach to cannabis use disorders,” Drug and Alcohol Dependence, vol. 100, no. 3, pp. 221–227, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. D. Piontek, L. Kraus, S. Legleye, and G. Bühringer, “The validity of DSM-IV cannabis abuse and dependence criteria in adolescents and the value of additional cannabis use indicators,” Addiction, vol. 106, no. 6, pp. 1137–1145, 2011. View at Publisher · View at Google Scholar · View at Scopus
  32. C. Y. Chen and J. C. Anthony, “Possible age-associated bias in reporting of clinical features of drug dependence: epidemiological evidence on adolescent-onset marijuana use,” Addiction, vol. 98, no. 1, pp. 71–82, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. T. Chung and C. S. Martin, “What were they thinking? Adolescents' interpretations of DSM-IV alcohol dependence symptom queries and implications for diagnostic validity,” Drug and Alcohol Dependence, vol. 80, no. 2, pp. 191–200, 2005. View at Publisher · View at Google Scholar · View at Scopus
  34. D. F. McCaffrey, R. L. Pacula, B. Han, and P. Ellickson, “Marijuana use and high school dropout: the influence of unobservables,” Health Economics, vol. 19, no. 11, pp. 1281–1299, 2010. View at Google Scholar · View at Scopus
  35. D. F. Ransohoff and A. R. Feinstein, “Problems of spectrum and bias in evaluating the efficacy of diagnostic tests,” New England Journal of Medicine, vol. 299, no. 17, pp. 926–930, 1978. View at Google Scholar · View at Scopus